Breaking: Pfizer Stock News and Forecast, PFE beats on Q2 2021 earnings

Ivan Brian FXStreet

Pfizer (PFE) reported Q2 2021 earnings on Wednesday, July 28 before the market opened. Pfizer reported Earnings Per Share (EPS) of $1.07 versus the average Wall Street analyst estimate of $0.96.

Revenue was $19 billion versus the average analyst estimate of $18.45 billion.

Pfizer also raised its full-year guidance from $70.5-72.5 billion to $78-80 billion and raises full-year EPS guidance from $3.55-3.65 to $3.95-4.05 range.

Pfizer raised sales forecasts for sales of the Covid-19 vaccine to $33.5 billion from $26 billion.

Pfizer stock forecast

Pfizer (PFE) stock is trading at $42.40 in Wednesday's premarket, a change of 0.7% . Pfizer closed Tuesday's regular session at $42.10, a change of +0.69% on Tuesday.

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to Premium Sign In

Author

Ivan Brian

FXStreet

Ivan Brian started his career with AIB Bank in corporate finance and then worked for seven years at Baxter. He started as a macro analyst before becoming Head of Research and then CFO.

EUR/USD struggles aroound 1.1800 as USD stabilizes

EUR/USD stays defensive around 1.1800 in the European session on Thursday. The US Dollar stabilizes, following the recent decline led by tariff uncertainty, capping the pair's upside. All eyes now remain on the US-Iran nuclear talks after ECB President Lagarde's testimony fails to impress Euro bulls.

GBP/USD drops toward 1.3500 as USD finds fresh demand

GBP/USD falls back toward 1.3500 in the European session on Thursday, snapping its recovery momentum. The pair loses traction as the US Dollar finds fresh demand, as markets turn cautious ahead of the US-Iran nuclear talks. The US trade policy uncertainty also remains a drag on risk sentiment.

Gold clings to gains amid sustained safe-haven flows ahead of US-Iran talks

Gold sticks to its modest intraday gains through the first half of the European session on Thursday, with bulls still awaiting a sustained move and acceptance above the $5,200 mark before placing fresh bets.

Stellar: Relief bounce fades as bearish undertone persists

Stellar is trading around $0.16 at the time of writing on Thursday after rebounding more than 8% in the previous day. Derivatives data paints a negative picture as XLM’s short bets hit a monthly high while Open Interest continues to decline.

The one thing everyone is on the lookout for is US action of some sort against Iran

The FX market is minestrone soup these days. It is befuddled by conflicting data, rumors and small stories exaggerated out of proportion, and Trump-generated uncertainty.

Solana strikes key resistance with double-digit gains

Solana trades at $88 at press time on Thursday, after an 11% upswing the previous day within a broader consolidation range of roughly three weeks. Institutional demand for Solana heightens as US spot SOL Exchange Traded Funds record $30 million of inflow on Wednesday.